1120 Antengene IPO
BioCentury & Getty Images


Mei readies Antengene to take its next steps to becoming a global biotech

Shanghai company with Celgene roots raises $360M Hong Kong IPO

Antengene, a Shanghai company with Celgene roots, looks to expand its pipeline and global footprint after $360 million IPO in Hong Kong.

Nov 21, 2020 | 4:11 AM GMT

Fresh off its $360 million IPO on the Hong Kong stock exchange, Shanghai’s Antengene is looking to take the next step in its evolution by building out its

Read the full 837 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers